ClinicalTrials.Veeva

Menu
O

Ochsner Health System | Ochsner Medical Complex - The Grove

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Afimetoran
Deucravacitinib

Parent organization

This site is a part of Ochsner Health System

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 4 total trials

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythema...

Active, not recruiting
Systemic Lupus Erythematosus
Other: Placebo
Drug: Afimetoran

The purpose of this study is to evaluate the safety and efficacy of deucravacitinib versus placebo for the treatment of participants with active PsA...

Active, not recruiting
Psoriatic Arthritis
Drug: Apremilast
Drug: Deucravacitinib

The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing th...

Enrolling
Clostridioides Difficile Associated Disease
Biological: C.difficile vaccine
Other: Saline Placebo

This is a Phase 2, multicenter study in adult participants with an acute COPD exacerbation and type 2 inflammation

Enrolling
COPD Acute Exacerbation
Combination Product: Rademikibart in prefilled syringe
Drug: Matching placebo in prefilled syringe

Trial sponsors

Bristol-Myers Squibb (BMS) logo
Pfizer logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems